Radiographic progression-free survival as a clinically meaningful end point in metastatic castration-resistant prostate cancer: The PREVAIL randomized clinical trial

March 12, 2018

Radiographic progression-free survival as a clinically meaningful end point in metastatic castration-resistant prostate cancer: The PREVAIL randomized clinical trial

Published on 03/11/2018

previous post: Can you use an inhaler after the expiration date?
next post: Progressive functional improvement in hemiglossectomy defects reconstructed with radial forearm free flap at 6-months